| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -37.09M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MBX returned +362.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +110.3% |
| 1 year | +362.9% |
| All-time high | $66.33 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MBX would be worth today ›No. MBX Biosciences, Inc. has not paid a dividend in the past 12 months.
MBX Biosciences, Inc. stock trades on NASDAQ under the ticker symbol MBX.
MBX Biosciences, Inc. is part of the Healthcare sector.
MBX Biosciences, Inc. has a market cap of 3.19B USD, based on the latest quote.
MBX Biosciences, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
